# Garyfallia Stefanou

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/garyfallia-stefanou/

## Facts

| Field | Value |
| --- | --- |
| Citations | 228 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 9 |
| i10-index | 8 |
| Last Known Institution | University of Peloponnese |
| OpenAlex ID | https://openalex.org/A5086509103 |
| ORCID iD | 0000-0002-1828-537X |
| Works | 40 |

## Researcher papers

- [SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial](https://scholariq.org/papers/sars-cov-2-specific-t-cell-therapy-for-severe-covid-19-a-randomized-phase-1-2/)
- [Unravelling the history of hepatitis B virus genotypes A and D infection using a full-genome phylogenetic and phylogeographic approach](https://scholariq.org/papers/unravelling-the-history-of-hepatitis-b-virus-genotypes-a-and-d-infection-using-a/)
- [A meta-analytic synthesis of early numeracy interventions for low-performing young children](https://scholariq.org/papers/a-meta-analytic-synthesis-of-early-numeracy-interventions-for-low-performing/)
- [Lung cancer patients' journey from first symptom to treatment: Results from a Greek registry](https://scholariq.org/papers/lung-cancer-patients-journey-from-first-symptom-to-treatment-results-from-a/)
- [Cardiorenal multimorbidity in hospitalized cardiology patients: The Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study](https://scholariq.org/papers/cardiorenal-multimorbidity-in-hospitalized-cardiology-patients-the-hellenic/)
- [PNS61 DOES A STANDARD WILLINGNESS-TO-PAY THRESHOLD EXIST IN GREECE?](https://scholariq.org/papers/pns61-does-a-standard-willingness-to-pay-threshold-exist-in-greece/)
- [The Effect of Time-Restricted Eating on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/the-effect-of-time-restricted-eating-on-cardiometabolic-risk-factors-a/)
- [Cost-effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Greece](https://scholariq.org/papers/cost-effectiveness-of-tofacitinib-for-the-treatment-of-moderate-to-severe-active/)
- [End-of-life cost for lung cancer patients in Greece: a hospital-based retrospective study](https://scholariq.org/papers/end-of-life-cost-for-lung-cancer-patients-in-greece-a-hospital-based/)
- [Prevalence of adult self-reported atopic dermatitis in Greece: results from a nationwide survey](https://scholariq.org/papers/prevalence-of-adult-self-reported-atopic-dermatitis-in-greece-results-from-a/)
- [Burden of Atopic Dermatitis in Adults in Greece: Results from a Nationwide Survey](https://scholariq.org/papers/burden-of-atopic-dermatitis-in-adults-in-greece-results-from-a-nationwide-survey/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

## Researcher university

- [University of Peloponnese](https://scholariq.org/institutions/university-of-peloponnese/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.